EP1333807A4 - Derives d'erythromycine a liberation prolongee - Google Patents
Derives d'erythromycine a liberation prolongeeInfo
- Publication number
- EP1333807A4 EP1333807A4 EP01986972A EP01986972A EP1333807A4 EP 1333807 A4 EP1333807 A4 EP 1333807A4 EP 01986972 A EP01986972 A EP 01986972A EP 01986972 A EP01986972 A EP 01986972A EP 1333807 A4 EP1333807 A4 EP 1333807A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- extended release
- erythromycin derivatives
- release erythromycin
- derivatives
- extended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68998800A | 2000-10-13 | 2000-10-13 | |
US689988 | 2000-10-13 | ||
PCT/US2001/032055 WO2002038577A2 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1333807A2 EP1333807A2 (fr) | 2003-08-13 |
EP1333807A4 true EP1333807A4 (fr) | 2005-06-29 |
Family
ID=24770642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01986972A Withdrawn EP1333807A4 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1333807A4 (fr) |
JP (1) | JP2004528272A (fr) |
AU (1) | AU2002239232A1 (fr) |
CA (1) | CA2425688A1 (fr) |
MX (1) | MXPA03003146A (fr) |
WO (1) | WO2002038577A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2005301970B2 (en) * | 2004-11-04 | 2011-06-02 | Arbor Pharmaceuticals, Llc | Gabapentin prodrug sustained release oral dosage forms |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019486A1 (fr) * | 1990-06-14 | 1991-12-26 | Kalmo Enterprises, Inc. | Suspensions de medicaments aqueuses stables |
US5707646A (en) * | 1992-03-12 | 1998-01-13 | Taisho Pharmaceutical Co., Ltd. | Taste masking pharmaceutical composition |
EP0826376A1 (fr) * | 1995-05-02 | 1998-03-04 | Taisho Pharmaceutical Co. Ltd | Composition s'administrant par voie orale |
US5780604A (en) * | 1997-09-26 | 1998-07-14 | Abbott Laboratories | 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides |
US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
WO2000054811A1 (fr) * | 1999-03-17 | 2000-09-21 | Daiichi Pharmaceutical Co., Ltd. | Compositions medicamenteuses |
WO2000069415A2 (fr) * | 1999-05-19 | 2000-11-23 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Granulation par fusion |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
JPS49107855A (fr) * | 1973-02-03 | 1974-10-14 | ||
JP2528652B2 (ja) * | 1987-03-30 | 1996-08-28 | エスエス製薬株式会社 | 持効性セフラジン製剤 |
US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
JPH07267850A (ja) * | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
JP2000169364A (ja) * | 1998-09-30 | 2000-06-20 | Taisho Pharmaceut Co Ltd | 経口製剤用粒子 |
-
2001
- 2001-10-12 EP EP01986972A patent/EP1333807A4/fr not_active Withdrawn
- 2001-10-12 CA CA002425688A patent/CA2425688A1/fr not_active Abandoned
- 2001-10-12 WO PCT/US2001/032055 patent/WO2002038577A2/fr not_active Application Discontinuation
- 2001-10-12 MX MXPA03003146A patent/MXPA03003146A/es unknown
- 2001-10-12 JP JP2002541109A patent/JP2004528272A/ja active Pending
- 2001-10-12 AU AU2002239232A patent/AU2002239232A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019486A1 (fr) * | 1990-06-14 | 1991-12-26 | Kalmo Enterprises, Inc. | Suspensions de medicaments aqueuses stables |
US5707646A (en) * | 1992-03-12 | 1998-01-13 | Taisho Pharmaceutical Co., Ltd. | Taste masking pharmaceutical composition |
EP0826376A1 (fr) * | 1995-05-02 | 1998-03-04 | Taisho Pharmaceutical Co. Ltd | Composition s'administrant par voie orale |
US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
US5780604A (en) * | 1997-09-26 | 1998-07-14 | Abbott Laboratories | 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides |
WO2000054811A1 (fr) * | 1999-03-17 | 2000-09-21 | Daiichi Pharmaceutical Co., Ltd. | Compositions medicamenteuses |
WO2000069415A2 (fr) * | 1999-05-19 | 2000-11-23 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Granulation par fusion |
Also Published As
Publication number | Publication date |
---|---|
MXPA03003146A (es) | 2004-12-06 |
AU2002239232A1 (en) | 2002-05-21 |
WO2002038577A2 (fr) | 2002-05-16 |
WO2002038577A3 (fr) | 2002-09-19 |
EP1333807A2 (fr) | 2003-08-13 |
JP2004528272A (ja) | 2004-09-16 |
CA2425688A1 (fr) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6053701A (en) | 2-aminocarbonyl-9h-purine derivatives | |
HRP20030055A2 (en) | 4-phenyl-pyridine derivatives | |
IL150841A0 (en) | 1h-imidazopyridine derivatives | |
IL145256A0 (en) | Erythromycin derivatives | |
IL155103A0 (en) | Substituted c-cyclohexylmethylamine derivatives | |
IL150557A0 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives | |
IL155106A0 (en) | Substituted 1-aminobutan-3-ol derivatives | |
HK1052499A1 (zh) | 氨基磺酰基聯苯基衍生物 | |
IL150558A0 (en) | Aminomethyl-phenyl-cyclohexanone derivatives | |
EP1333807A4 (fr) | Derives d'erythromycine a liberation prolongee | |
IL155104A0 (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
IL151598A0 (en) | 2-phenylpyran-4-one derivatives | |
GB0031306D0 (en) | Macrolides | |
GB0025687D0 (en) | Macrolides | |
GB0025689D0 (en) | Macrolides | |
GB0025691D0 (en) | Macrolides | |
GB0025683D0 (en) | Macrolides | |
GB0031309D0 (en) | Macrolides | |
GB0025685D0 (en) | Macrolides | |
GB0031313D0 (en) | Macrolides | |
GB0031314D0 (en) | Macrolides | |
GB0031311D0 (en) | Macrolides | |
HK1054937A1 (en) | 1-Methylcarbapenem derivatives | |
GB0021639D0 (en) | Maurotoxin derivatives | |
SI1246793T1 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030509 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: RUDNIC, EDWARD, M. Inventor name: TREACY, DONALD, J., JR. Inventor name: WASSINK, SANDRA, E. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050518 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 31/7048 B Ipc: 7A 61K 47/14 B Ipc: 7A 61K 47/10 B Ipc: 7A 61K 47/02 B Ipc: 7A 61K 9/22 B Ipc: 7A 61K 9/20 A |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050803 |